News
6d
Investor's Business Daily on MSNAcadia Emerges From Behind The Scenes With A Potential $12 Billion OpportunityAcadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
6d
The Observer on MSNTripping down memory lane: the psychedelic therapy boomPreviously confined to fringe enthusiasts, psychedelic therapy is experiencing a renaissance, championed by the singer Lorde, ...
Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
Benadryl has been associated with worse school performance and, in one small study, impaired people’s ability to drive more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results